Login / Signup

Medication utilization and lung function changes after initiation of treatment with elexacaftor/tezacaftor/ivacaftor.

Richard De VuystCharissa W KamCameron J McKinzieCharles R Esther
Published in: Pediatric pulmonology (2024)
Keyphrases
  • lung function
  • cystic fibrosis
  • chronic obstructive pulmonary disease
  • air pollution
  • emergency department
  • adverse drug
  • replacement therapy